Add like
Add dislike
Add to saved papers

Using SAS/STAT to Understand the NCI Joinpoint Regression Software: Testing for a Zero Slope Using Rates of Drug Overdose Deaths Involving Fentanyl, 2011-2016.

Background-The National Cancer Institute (NCI) Joinpoint regression software is a widely used software program for evaluating trends. In addition to producing model estimates for trend models, this software can search for changes in slope along the trend line. One component of the software, which tests whether line segment slopes are zero, is different from the usual t-test of zero slope that is used in linear models. This report will demonstrate this Joinpoint software procedure through replication using the SAS Institute's statistical software (that is, SAS) and discuss the implications of the different assumptions used by Joinpoint and a typical SAS model for the test of zero slope. Methods-First, Joinpoint's procedure for testing a zero slope is compared with a typical test of zero slope using SAS, and the assumptions behind both approaches are evaluated. Second, the test from the Joinpoint software is replicated in SAS using its PROC REG procedure and additional SAS programming. Trend analyses of rates of drug overdose deaths involving fentanyl from the general population and among females are used as examples. Results-In the evaluation of the trend of drug overdose deaths for the total population, Joinpoint produces a similar result to the linear model test in SAS. For the female subgroup, however, Joinpoint and SAS produce differing results for the test of zero slope. The replication of the Joinpoint test of zero slope using SAS demonstrates that Joinpoint's procedure is based on fewer degrees of freedom, which results in a larger standard error estimate. Conclusion-The Joinpoint approach accounts for the fact that the joinpoints are estimated and thus leads to a more conservative hypothesis test, particularly when the number of points in a trend analysis is small.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app